To develop and evaluate an artificial intelligence-based clinical decision support system to improve the accuracy and clinical utility of stroke diagnosis in pre-hospital settings and to ultimately optimize time to treatment decisions, allowing more patients to benefit from thrombolytics.
Borsody et al. (Tue,) studied this question.